INMED PHARMACEUTICALS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.265 USD | -4.33% |
|
+0.76% | -36.30% |
| May. 14 | Earnings Flash (INM) INMED PHARMACEUTICALS Posts Q3 Revenue $1.2M | MT |
| May. 14 | InMed Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-07-09 | 2024-07-10 | 2024-07-11 | 2024-07-12 | |
|---|---|---|---|---|
| Last | 0.245 $ | 0.263 $ | 0.277 $ | 0.265 $ |
| Volume | 138 143 | 320 556 | 2 110 740 | 573 728 |
| Change | -5.51% | +7.35% | +5.32% | -4.33% |
| Opening | 0.25 | 0.24 | 0.26 | 0.28 |
| High | 0.26 | 0.27 | 0.29 | 0.28 |
| Low | 0.24 | 0.24 | 0.25 | 0.25 |
Performance
| 1 day | -4.33% | ||
| 1 week | +0.76% | ||
| Current month | -0.19% | ||
| 1 month | +10.55% | ||
| 3 months | -19.58% | ||
| 6 months | -30.72% | ||
| Current year | -36.30% | ||
| 1 year | -73.76% | ||
| 3 years | -99.64% | ||
| 5 years | -99.88% | ||
| 10 years | -99.94% |
Volumes
marketsDaily volume
573 728
Estimated daily volume
573 728
Avg. Volume 20 sessions
737 940
Daily volume ratio
0.78
Avg. Volume 20 sessions USD
195 554.10
Record volume 1
101 956 587
Record volume 2
31 937 460
Record volume 3
28 460 050
Capital turnover ratio
0.08
Float rotation
0.05
Basic data
Capitalization (USD)
2 363 523
Net sales (CAD)
5 594 380
Net sales (USD)
4 100 681
Number of employees
13
Sales / Employee (CAD)
430 337
Sales / Employee (USD)
315 437
Free-Float
99.42 %
Free-Float capitalization (USD)
3 724 443
Average Daily Capital Traded
6.06%
Highs and lows
1 week
0.24
0.29
1 month
0.210.31
Current year
0.210.47
1 year
0.212.08
3 years
0.2173.75
5 years
0.21277.20
10 years
0.211 608.75
Indicators
Moving average 5 days
0.26
Moving average 20 days
0.25
Moving average 50 days
0.27
Moving average 100 days
0.31
Price spread / (MMA5)
-1.17%
Price spread / (MMA20)
-4.08%
Price spread / (MMA50)
+2.00%
Price spread / (MMA100)
+16.49%
STIM
RSI 9 days
58.59
RSI 14 days
54.16
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -4.33% | +0.76% | -36.30% | -73.76% | 2.36M | ||
| -0.69% | +2.99% | +20.12% | +41.23% | 126B | ||
| +1.83% | +6.36% | +25.25% | +53.12% | 119B | ||
| +0.33% | +7.10% | +25.56% | +27.45% | 27.95B | ||
| +0.30% | +6.07% | -19.51% | -22.06% | 20.5B | ||
| +2.64% | +5.16% | -14.36% | -28.39% | 17.12B | ||
| +1.11% | +3.49% | -15.63% | -20.77% | 16.1B | ||
| -0.05% | +2.05% | -46.67% | -38.80% | 14.97B | ||
| +0.63% | +6.00% | +11.89% | +51.63% | 14.84B | ||
| 0.00% | +0.25% | +57.74% | +40.86% | 14.38B | ||
| -0.42% | +9.59% | +147.53% | +277.70% | 12.37B | ||
| -0.32% | -2.58% | +147.72% | +301.96% | 9.55B | ||
| +0.52% | +5.91% | +31.19% | +72.11% | 8.96B | ||
| +12.10% | +17.43% | -9.64% | -21.92% | 9.91B | ||
| +1.75% | +1.67% | +9.63% | +59.52% | 7.92B | ||
| -1.80% | -1.59% | -4.93% | +32.60% | 7.34B | ||
| Average | +0.85% | +4.62% | +20.60% | +47.03% | ||
| Weighted average by Cap. | +0.78% | +4.91% | +21.37% | +45.06% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
ecea83f.pq8XcHFFY_YqI-h9uIQD2S7OijzX9rwe9il75okPZ24.i-ghIgUNLLF_dYNQjrBo9GCv_3Wfx9JyhlpCoLA9Cj7r3mYJNw0bvBtk2A
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 0.265 | 402 | 543,142 |
| 03:59:38 pm | 0.2639 | 100 | 542,740 |
| 03:59:37 pm | 0.2687 | 800 | 542,640 |
| 03:59:18 pm | 0.2639 | 200 | 541,840 |
| 03:59:18 pm | 0.2639 | 100 | 541,640 |
| 03:59:18 pm | 0.2639 | 347 | 541,540 |
| 03:58:17 pm | 0.2645 | 100 | 541,193 |
| 03:58:17 pm | 0.2645 | 100 | 541,093 |
| 03:58:17 pm | 0.2645 | 100 | 540,993 |
| 03:58:17 pm | 0.2645 | 200 | 540,893 |
Monthly variations
Annual change
| 2024 | -36.30% | ||
| 2023 | -79.41% | ||
| 2022 | -93.83% | ||
| 2021 | -60.18% | ||
| 2020 | -44.61% | ||
| 2019 | -29.40% | ||
| 2018 | -76.05% | ||
| 2017 | +526.24% | ||
| 2016 | +47.83% | ||
| 2015 | -4.17% | ||
| 2014 | -53.49% |
- Stock Market
- Equities
- INM Stock
- Quotes InMed Pharmaceuticals Inc.
